BRCA2 and breast cancer: Some genotype–phenotype correlations have been identified, highlighting some regions of BRCA1 and BRCA2 and types of pathogenic variants as features related to increased lifetime risk of BC or OC regions; however, these are not currently used for personalizing screening and preventive strategies [10,27,28,29,30].